Vol 9, No 6 (2020)
Research paper
Published online: 2020-11-19

open access

Page views 645
Article views/downloads 615
Get Citation

Connect on Social Media

Connect on Social Media

Factors associated with control of type 2 diabetes mellitus in North Iran

Vahid Bay, Irvan Masoudi Asl, Alireza Mahdavi Hezaveh, Mahboobeh Asadzadeh, Alireza Heidari, Elaheh Yazarloo
Clin Diabetol 2020;9(6):426-432.


Backround. Diabetes is an important public health problem, one of four priority noncommunicable diseases targeted for action by world leaders. The aim of this study was to investigate the factors affecting diabetes control in patients with type 2 diabetes in the rural areas of northern Iran. Methods. This study was conducted following a descriptive-analytical cross-sectional study design based on the data of 308 patients with type 2 diabetes in the rural areas of Golestan province. The samples were selected through two-stage stratified random sampling. Data were collected using a questionnaire (completed by the interviewer) and by measuring the blood glucose, blood pressure, and lipid profile of patients and also using data from patients’ records. Data were analyzed using descriptive and analytical statistics and SPSS version 19. Results. The mean age of patients was 57 ± 15 years and 220 patients (71%) were female. Fifty-five percent of patients had a family history of diabetes and 69% had comorbidity. The mean vegetable intake in patients was 3 days a week with 1.5 servings per day and only 20% had exercise at least three times a week. The proportion of patients with adequately controlled glycated hemoglobin (HBA1c), blood pressure (BP), triglyceride (TG), low-density lipoprotein (LDL), and high-density lipoprotein (HDL) were 27, 91, 31, 41 and 55.5%, respectively. There was also a significant relationship between the controlled blood glucose with increasing age, absence of comorbidity, the number of nutrition counseling, and lowering blood triglycerides. Conclusion. The results of this study showed poor blood glucose control in the studied geography. Therefore, considering these data, it seems necessary to review the national plan for the prevention and control of diabetes.

Article available in PDF format

View PDF Download PDF file


  1. Organization WH. Global report on diabetes. 2016. https://www.who.int/publications-detail-redirect/9789241565257.
  2. IDF DIABETES ATLAS Eighth edition 2017. International Diabetes Federation 2017.
  3. World Health Organization. Facts Sheets. http://who.int/mediacentre/factsheets/fs312/en/.
  4. Ministry of Health and Medical Education. Golestan University of Medical Sciences. prevalence of diabet in golestan province. 2017 May 29.
  5. Fallah S, Rostamzadeh S. Success of the Family Practice Plan in Diabetes Control. Journal of Health. 2016; 7(4): 417–24.
  6. Khazaei S, Saatchi A, Mirmoeini R, et al. Assessing Treatment and Care in Patients with Type 2 Diabetes in Rural Regions of Hamadan Province in 2013. Scientific Journal of Hamadan University of Medical Sciences. 2015; 21(4): 318.
  7. Delpisheh A, Azizi H, Dantalab Es, et al. QUALITY OF CARE AND BLOOD SUGAR CONTROL IN TYPE ΙΙ DIABETIC PATIENTS OF RURAL AREAS UNDER THE CARE BY FAMILY PHYSICIANS. Iranian Journal of Diabetes and Metabolism. 2016; 14(3): 189–198.
  8. Al-Kaabi J, Al-Maskari F, Saadi H, et al. Physical activity and reported barriers to activity among type 2 diabetic patients in the United arab emirates. Rev Diabet Stud. 2009; 6(4): 271–278.
  9. Al Balushi KA, Al-Haddabi M, Al-Zakwani I, et al. Glycemic control among patients with type 2 diabetes at a primary health care center in Oman. Prim Care Diabetes. 2014; 8(3): 239–243.
  10. Alsulaiman TA, Al-Ajmi HA, Al-Qahtani SM, et al. Control of type 2 diabetes in King Abdulaziz Housing City (Iskan) population, Saudi Arabia. J Family Community Med. 2016; 23(1): 1–5.
  11. Yue J, Mao X, Xu K, et al. Prevalence, Awareness, Treatment and Control of Diabetes Mellitus in a Chinese Population. PLoS One. 2016; 11(4): e0153791.
  12. Ding L, Xu Yu, Wang L, et al. 2010 China Non-communicable Disease Surveillance Group, 2010 China Non-communicable Disease Surveillance Group, 2010 China Noncommunicable Disease Surveillance Group, 2010 China Noncommunicable Disease Surveillance Group. Prevalence and control of diabetes in Chinese adults. JAMA. 2013; 310(9): 948–959.
  13. Ghorbani Be, Yazdanbood A, Amini Sa, et al. Quality of care in 100 diabetic patients in a diabetes clinic in Ardabil. Journal of Ardabil University of Medical Sciences. 2012; 12(3): 239–247.
  14. Mahmood MI, Daud F, Ismail A. Glycaemic control and associated factors among patients with diabetes at public health clinics in Johor, Malaysia. Public Health. 2016; 135: 56–65.
  15. Heidari S, Shirazi F, Sanjari M, et al. Factors influencing glycemic control in type 2 diabetic patients referred to the Institute of Endocrinology and Metabolism, University of Iran Medical Sciences. Iranian Journal of Diabetes and Lipid. 2010; 9(4): 365–375.
  16. Amini M, Mehdigoya M, Delavaei A, et al. Quality of diabetic management in Iran in 2004-2006. Journal of Medical Council of Islamic Republic of IRAN. 2008: 20–29.
  17. Montazem SH, Soleimani A, Hosseini SH, et al. Care quality of patients with diabetes type 2 in the rural areas of Malekan, Iran. Journal of North Khorasan University of Medical Sciences. 2011; 3(3): 75–82.
  18. Al Mansari A, Obeid Y, Islam N, et al. GOAL study: clinical and non-clinical predictive factors for achieving glycemic control in people with type 2 diabetes in real clinical practice. BMJ Open Diabetes Res Care. 2018; 6(1): e000519.
  19. Kassahun T, Eshetie T, Gesesew H. Factors associated with glycemic control among adult patients with type 2 diabetes mellitus: a cross-sectional survey in Ethiopia. BMC Res Notes. 2016; 9: 78.
  20. Hashemi Nazari S, Bigdelli MA, Khodakarim S, et al. ESTIMATING THE EFFECT OF DIRECT AND INDIRECT FACTORS ON GLYCEMIC CONTROL IN TYPE II DIABETIC PATIENTS BY PATH ANALYSIS. Iranian Journal of Diabetes and Metabolism. 2018; 2(1).
  21. Alramadan MJ, Afroz A, Hussain SM, et al. Patient-Related Determinants of Glycaemic Control in People with Type 2 Diabetes in the Gulf Cooperation Council Countries: A Systematic Review. J Diabetes Res. 2018; 2018: 9389265.
  22. Takahashi PY, St Sauver JL, Finney Rutten LJ, et al. Health outcomes in diabetics measured with Minnesota Community Measurement quality metrics. Diabetes Metab Syndr Obes. 2015; 8: 1–8.
  23. Husdal R, Thors Adolfsson E, Leksell J, et al. Associations between quality of work features in primary health care and glycaemic control in people with Type 2 diabetes mellitus: A nationwide survey. Prim Care Diabetes. 2019; 13(2): 176–186.
  24. Iranparvar Alamdari M, Yazdanbood A, Islam Panah S. Quality of care in100diabetic patients in a diabetes clinic in Ardabil. Ardabil J Med Sci. 2012; 12(3): 239–247.
  25. Badedi M, Solan Y, Darraj H, et al. Factors Associated with Long-Term Control of Type 2 Diabetes Mellitus. J Diabetes Res. 2016; 2016: 2109542.
  26. Hu H, Hori Ai, Nishiura C, et al. Japan Epidemiology Collaboration on Occupational Health Study Group. Hba1c, Blood Pressure, and Lipid Control in People with Diabetes: Japan Epidemiology Collaboration on Occupational Health Study. PLoS One. 2016; 11(7): e0159071.
  27. Nanayakkara N, Ranasinha S, Gadowski AM, et al. Age-related differences in glycaemic control, cardiovascular disease risk factors and treatment in patients with type 2 diabetes: a cross-sectional study from the Australian National Diabetes Audit. BMJ Open. 2018; 8(8): e020677.
  28. Care D. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes — 2019. Diabetes Care. 2018; 42(Supplement 1): S13–S28.
  29. Long AN, Dagogo-Jack S. Comorbidities of diabetes and hypertension: mechanisms and approach to target organ protection. J Clin Hypertens (Greenwich). 2011; 13(4): 244–251.
  30. Nowakowska M, Zghebi SS, Ashcroft DM, et al. The comorbidity burden of type 2 diabetes mellitus: patterns, clusters and predictions from a large English primary care cohort. BMC Med. 2019; 17(1): 145.